Susquehanna International Group
SEEL

Susquehanna International Group’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Susquehanna International Group’s Portfolio SEEL Stock Details SEEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-5
Closed -$3.19K – 13508
2023
Q3 		$3.19K Sell
5
-7
-58% -$30K ﹤0.01% 11820
2023
Q2 		$53.6K Hold
12
– – ﹤0.01% 11310
2023
Q1 		$31.7K Sell
12
-35
-74% -$102K ﹤0.01% 11891
2022
Q4 		$122K Buy
47
+13
+38% +$45.3K ﹤0.01% 10744
2022
Q3 		$135K Buy
34
+20
+143% +$78.6K ﹤0.01% 11387
2022
Q2 		$35K Sell
14
-8
-36% -$20.8K ﹤0.01% 12154
2022
Q1 		$70K Buy
22
+13
+144% +$55.9K ﹤0.01% 12136
2021
Q4 		$59K Sell
9
-7
-44% -$53.7K ﹤0.01% 12464
2021
Q3 		$148K Sell
16
-45
-74% -$387K ﹤0.01% 11807
2021
Q2 		$623K Hold
61
– – ﹤0.01% 9035
2021
Q1 		$1.16M Buy
+61
New +$712K ﹤0.01% 7326
2015
Q3 		– Hold
0
– -$30K – 10318
2015
Q2 		– Hold
0
– – – 9947
2015
Q1 		– Hold
0
– – – 9242
2014
Q4 		– Hold
0
– – – 9514
2014
Q3 		– Hold
0
– – – 9297
2014
Q2 		– Hold
0
– – – 9643
2014
Q1 		– Hold
0
– – – 8778
2013
Q4 		– Hold
0
– – – 8580
2013
Q3 		– Hold
0
– – – 7475
2013
Q2 		– Hold
0
– – – 6178

Other funds holding SEEL

WE
Wealth Effects Boston, Massachusetts $370M AUM 97.79% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MWM
Modera Wealth Management Westwood, New Jersey $9.37B AUM 23.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SFWC
Strategic Family Wealth Counselors Fairfield, New Jersey $381M AUM 21.36% 1-Year Est. Return

Susquehanna International Group's SEEL Position: Q4 2023 in Review

Susquehanna International Group sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q4 2023, closing a stake of 27 shares — an estimated $13.3K sold.

Susquehanna International Group first reported a position in SEEL in Q3 2019 and held it in 11 quarters. The position peaked at $2.7M in Q1 2021. 32 funds tracked by Wall St. Rank hold SEEL as of Q4 2023.

  • Susquehanna International Group reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Susquehanna International Group sold 27 Seelos Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $13.3K.
  • Susquehanna International Group first reported a position in Seelos Therapeutics, Inc. Common Stock in Q3 2019 and held it in 11 quarters.
  • Susquehanna International Group's Seelos Therapeutics, Inc. Common Stock position peaked at $2.7M in Q1 2021.
  • 32 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.